semaglutide fda indications approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Novo Nordisk receives FDA approval
Description
Mounjaro (tirzepatide) injection still leads on magnitude, with around 20% average weight loss at the highest dose when paired with lifestyle support
You feel fuller faster and longer, leading to reduced calorie intake without feeling like you're starving yourself
If you have somebody on the blood pressure tablet, you stop the tablet, almost inevitably the blood pressure rises
It empowers patients to take control of their health with confidence while receiving ongoing support from trusted providers
